Drug
Enfuvirtide
Enfuvirtide: highest development phase Post-Market, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| enfuvirtide NCT02569502 | Post-Market | HIV Infections |
Latest
No recent events.
Follow Enfuvirtide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.